Skip to content

Boehringer-Ingelheim begins trial of once-daily extended release nevirapine

CROI: Region of origin and gender significant in long-term changes in CD4 cell count during effective HIV therapy

CROI: Tetherin: a newly discovered host cell protein that inhibits HIV replication

Reckless HIV transmission case dismissed due to insufficient evidence (amended)

CROI: Recreational drug use a risk for asymptomatic heart disorders in HIV-positive patients

CROI: Once daily Kaletra tablets non-inferior to twice daily dose

CROI: Risk of lymphomas depends on cumulative viral load and latest CD4 counts

CROI: Tenofovir plus emtricitabine safe and effective when added to nevirapine for PMTCT

CROI: HAART Breastfeeding study detects drug resistance in HIV-infected infants